PANE, FABRIZIO
PANE, FABRIZIO
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
Fine needle aspiration cytology and flow cytometry immunophenotyping of non-Hodgkin lymphoma: can we do better?.
2010 Zeppa, P; Vigliar, E; Cozzolino, Immacolata; Troncone, Giancarlo; Picardi, Marco; DE RENZO, Amalia; Grimaldi, F; Pane, Fabrizio; Vetrani, Antonio; Palombini, Lucio
ALEMTUZUMAB FOR APLASTIC ANEMIA AND RELATED IMMUNE-MEDIATED BONE MARROW FAILURES: LONG-TERM FOLLOW UP OF A PILOT STUDY
2011 Risitano, ANTONIO MARIA; Selleri, Carmine; Serio, Bianca; Marando, L.; Marotta, Serena; Raia, M.; De Palma, R.; DEL VECCHIO, Luigi; DE ROSA, Gennaro; Pane, Fabrizio
Modified Nucleosides in Human Blood Serum as Biochemical Signal for Neoplasia
1990 Salvatore, Francesco; Sacchetti, Lucia; Savoia, Marcella; Pane, Fabrizio; Russo, Tommaso; Cimino, Filiberto; Colonna, Alfredo
THIOTEPA AND MELPHALAN AS NEW CONDITIONING REGIMEN FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE LYELOMA
2013 Grimaldi, Francesco; Madonna, Emanuela; Avilia, Simona; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro
Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials.
2008 Susan, Branford; Linda, Fletcher; Nicholas, C. P.; Martin C., Müller; Andreas, Hochhaus; Dong Wook, Kim; Jerald P., Radich; Giuseppe, Saglio; Pane, Fabrizio; Suzanne Kamel, Reid; Y., Lynn Wang; Richard D., Press; Kevin, Lynch; Zbigniew, Rudzki; John M., Goldman; Timothy, Hughes
Front-line treatment of Philadelphia positive chronic myeloid leukemia with imatinib and interferon-alpha: 5-year outcome.
2008 Francesca, Palandri; Ilaria, Iacobucci; Fausto, Castagnetti; Nicoletta, Testoni; Angela, Poerio; Marilina, Amabile; Massimo, Breccia; Tamara, Intermesoli; Francesco, Iuliano; Giovanna Rege, Cambrin; Mario, Tiribelli; Maurizio, Miglino; Pane, Fabrizio; Giuseppe, Saglio; Giovanni, Martinelli; Gianantonio, Rosti; Michele, Baccarani; G. I., M.
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia.
2008 Francesco Lo, Coco; Antonio, Cuneo; Pane, Fabrizio; Daniela, Cilloni; Daniela, Diverio; Marco, Mancini; Nicoletta, Testoni; Antonella, Bardi; Izzo, Barbara; Niccolò, Bolli; Roberta La, Starza; Paola, Fazi; Simona, Iacobelli; Alfonso, Piciocchi; Marco, Vignetti; Sergio, Amadori; Franco, Mandelli; Pier Giuseppe, Pelicci; Cristina, Mecucci; Brunangelo, Falini; Giuseppe, Saglio; Acute Leukemia, Working
Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate
2007 Alimena, G; Breccia, M; Luciano, L; Quarantelli, F; Diverio, D; Izzo, Barbara; DE ANGELIS, B; Mancini, M; Latagliata, R; Carmosino, I; Nanni, M; Picardi, Marco; Rotoli, B; Mandelli, F; Pane, Fabrizio
Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method.
2008 Ilaria, Iacobucci; Annalisa, Lonetti; Daniela, Cilloni; Francesca, Messa; Anna, Ferrari; Roberta, Zuntini; Simona, Ferrari; Emanuela, Ottaviani; Francesca, Arruga; Stefania, Paolini; Cristina, Papayannidis; Pier Paolo, Piccaluga; Simona, Soverini; Giuseppe, Saglio; Pane, Fabrizio; Anna, Baruzzi; Marco, Vignetti; Giorgio, Berton; Antonella, Vitale; Sabina, Chiaretti; Markus, Müschen; Robin, Foà; Michele, Baccarani; Giovanni, Martinelli
Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance.
2008 Ilaria, Iacobucci; Annalisa, Lonetti; Francesca, Messa; Daniela, Cilloni; Francesca, Arruga; Emanuela, Ottaviani; Stefania, Paolini; Cristina, Papayannidis; Pier Paolo, Piccaluga; Panagiota, Giannoulia; Simona, Soverini; Marilina, Amabile; Angela, Poerio; Giuseppe, Saglio; Pane, Fabrizio; Giorgio, Berton; Anna, Baruzzi; Antonella, Vitale; Sabina, Chiaretti; Giovanni, Perini; Robin, Foà; Michele, Baccarani; Giovanni, Martinelli
Serum pseudouridine in the diagnosis of acute leukaemias and as a novel prognostic indicator in acute lymphoblastic leukaemia
1993 Pane, Fabrizio; Savoia, Marcella; Fortunato, G.; Camera, A.; Rotoli, B.; Salvatore, F.; Sacchetti, L.
Simultaneous occurrence of tetrasomy 21 and trisomy 8 in a patient with early blastic metamorphosis of chronic myeloproliferative disorder.
1995 Sebastio, L.; Ferrara, F.; Vicari, L.; DI NOTO, Rosa; DEL VECCHIO, Luigi; Pane, Fabrizio; Fasanaro, A.; Cimino, R.; Salvatore, Francesco; Ventruto, V.
Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, philadelphia-positive chronic myeloid leukemia: the GIMEMA Working Party on CML.
2008 Francesca, Palandri; Ilaria, Iacobucci; Giovanni, Martinelli; Marilina, Amabile; Angela, Poerio; Nicoletta, Testoni; Simona, Soverini; Fausto, Castagnetti; Antonio De, Vivo; Massimo, Breccia; Giorgina, Specchia; Elisabetta, Abruzzese; Bruno, Martino; Daniela, Cilloni; Giuseppe, Saglio; Pane, Fabrizio; Anna Marina, Liberati; Gianantonio, Rosti; Michele, Baccarani; G. I., M.
NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia.
2008 Brunangelo, Falini; Cristina, Mecucci; Giuseppe, Saglio; Francesco Lo, Coco; Daniela, Diverio; Patrick, Brown; Pane, Fabrizio; Marco, Mancini; Maria Paola, Martelli; Stefano, Pileri; Torsten, Haferlach; Claudia, Haferlach; Susanne, Schnittger
Complete remission in a case of severe multi-resistant idiopathic thrombocytopenic purpura after Helicobacter pylori eradication.
2008 Ciro Roberto, Rinaldi; Andrea, Camera; Giovanni, Viscardi; Pane, Fabrizio; Bruno, Rotoli
Livelli sierici degli isoenzimi della LDH e della pseudoridina in leucemie e linfomi
1987 Camera, A.; Savoia, Marcella; Fortunato, G.; Pane, Fabrizio; Buffardi, S.; Rotoli, B.; Salvatore, F.; Sacchetti, L.
Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: tyrosine kinase inhibitor optimization and selectivity study.
2010 Cortes, Je; Baccarani, M; Guilhot, F; Druker, Bj; Branford, S; Kim, Dw; Pane, Fabrizio; Pasquini, R; Goldberg, Sl; Kalaycio, M; Moiraghi, B; Rowe, Jm; Tothova, E; De Souza, C; Rudoltz, M; Yu, R; Krahnke, T; Kantarjian, Hm; Radich, Jp; Hughes, T. P.
Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan.
2010 Ferrara, F.; Izzo, T.; Criscuolo, C.; Riccardi, C.; Muccioli, G.; Viola, A.; Pane, Fabrizio; Palmieri, S.
Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis.
2010 Castagnetti, F.; Testoni, N.; Luatti, S.; Marzocchi, G.; Mancini, M.; Kerim, S.; Giugliano, E.; Albano, F.; Cuneo, A.; Abruzzese, E.; Martino, B.; Palandri, F.; Amabile, M.; Iacobucci, I.; Alimena, G.; Pane, Fabrizio; Martinelli, G.; Saglio, G.; Baccarani, M.; Rosti, G.
New insights into the Bcr-Abl activity-independent mechanisms of resistance to imatinib mesylate in KCL22 cells: the role of Shp1 and Shp2
2010 Colavita, Irene; Esposito, Nicola; Martinelli, Rosanna; Catanzano, Francesca; Pane, Fabrizio; Ruoppolo, Margherita; Salvatore, Francesco
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Fine needle aspiration cytology and flow cytometry immunophenotyping of non-Hodgkin lymphoma: can we do better?. | 1.1 Articolo in rivista | 2010 | Zeppa, P; Vigliar, E; Cozzolino, Immacolata; Troncone, Giancarlo; Picardi, Marco; DE RENZO, Amalia; Grimaldi, F; Pane, Fabrizio; Vetrani, Antonio; Palombini, Lucio | |
| ALEMTUZUMAB FOR APLASTIC ANEMIA AND RELATED IMMUNE-MEDIATED BONE MARROW FAILURES: LONG-TERM FOLLOW UP OF A PILOT STUDY | 1.5 Abstract in rivista | 2011 | Risitano, ANTONIO MARIA; Selleri, Carmine; Serio, Bianca; Marando, L.; Marotta, Serena; Raia, M.; De Palma, R.; DEL VECCHIO, Luigi; DE ROSA, Gennaro; Pane, Fabrizio | |
| Modified Nucleosides in Human Blood Serum as Biochemical Signal for Neoplasia | 1.1 Articolo in rivista | 1990 | Salvatore, Francesco; Sacchetti, Lucia; Savoia, Marcella; Pane, Fabrizio; Russo, Tommaso; Cimino, Filiberto; Colonna, Alfredo | |
| THIOTEPA AND MELPHALAN AS NEW CONDITIONING REGIMEN FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE LYELOMA | 1.5 Abstract in rivista | 2013 | Grimaldi, Francesco; Madonna, Emanuela; Avilia, Simona; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro | |
| Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials. | 1.1 Articolo in rivista | 2008 | Susan, Branford; Linda, Fletcher; Nicholas, C. P.; Martin C., Müller; Andreas, Hochhaus; Dong Wook, Kim; Jerald P., Radich; Giuseppe, Saglio; Pane, Fabrizio; Suzanne Kamel, Reid; Y., Lynn Wang; Richard D., Press; Kevin, Lynch; Zbigniew, Rudzki; John M., Goldman; Timothy, Hughes | |
| Front-line treatment of Philadelphia positive chronic myeloid leukemia with imatinib and interferon-alpha: 5-year outcome. | 1.1 Articolo in rivista | 2008 | Francesca, Palandri; Ilaria, Iacobucci; Fausto, Castagnetti; Nicoletta, Testoni; Angela, Poerio; Marilina, Amabile; Massimo, Breccia; Tamara, Intermesoli; Francesco, Iuliano; Giovanna Rege, Cambrin; Mario, Tiribelli; Maurizio, Miglino; Pane, Fabrizio; Giuseppe, Saglio; Giovanni, Martinelli; Gianantonio, Rosti; Michele, Baccarani; G. I., M. | |
| Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia. | 1.1 Articolo in rivista | 2008 | Francesco Lo, Coco; Antonio, Cuneo; Pane, Fabrizio; Daniela, Cilloni; Daniela, Diverio; Marco, Mancini; Nicoletta, Testoni; Antonella, Bardi; Izzo, Barbara; Niccolò, Bolli; Roberta La, Starza; Paola, Fazi; Simona, Iacobelli; Alfonso, Piciocchi; Marco, Vignetti; Sergio, Amadori; Franco, Mandelli; Pier Giuseppe, Pelicci; Cristina, Mecucci; Brunangelo, Falini; Giuseppe, Saglio; Acute Leukemia, Working | |
| Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate | 1.1 Articolo in rivista | 2007 | Alimena, G; Breccia, M; Luciano, L; Quarantelli, F; Diverio, D; Izzo, Barbara; DE ANGELIS, B; Mancini, M; Latagliata, R; Carmosino, I; Nanni, M; Picardi, Marco; Rotoli, B; Mandelli, F; Pane, Fabrizio | |
| Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method. | 1.1 Articolo in rivista | 2008 | Ilaria, Iacobucci; Annalisa, Lonetti; Daniela, Cilloni; Francesca, Messa; Anna, Ferrari; Roberta, Zuntini; Simona, Ferrari; Emanuela, Ottaviani; Francesca, Arruga; Stefania, Paolini; Cristina, Papayannidis; Pier Paolo, Piccaluga; Simona, Soverini; Giuseppe, Saglio; Pane, Fabrizio; Anna, Baruzzi; Marco, Vignetti; Giorgio, Berton; Antonella, Vitale; Sabina, Chiaretti; Markus, Müschen; Robin, Foà; Michele, Baccarani; Giovanni, Martinelli | |
| Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance. | 1.1 Articolo in rivista | 2008 | Ilaria, Iacobucci; Annalisa, Lonetti; Francesca, Messa; Daniela, Cilloni; Francesca, Arruga; Emanuela, Ottaviani; Stefania, Paolini; Cristina, Papayannidis; Pier Paolo, Piccaluga; Panagiota, Giannoulia; Simona, Soverini; Marilina, Amabile; Angela, Poerio; Giuseppe, Saglio; Pane, Fabrizio; Giorgio, Berton; Anna, Baruzzi; Antonella, Vitale; Sabina, Chiaretti; Giovanni, Perini; Robin, Foà; Michele, Baccarani; Giovanni, Martinelli | |
| Serum pseudouridine in the diagnosis of acute leukaemias and as a novel prognostic indicator in acute lymphoblastic leukaemia | 1.1 Articolo in rivista | 1993 | Pane, Fabrizio; Savoia, Marcella; Fortunato, G.; Camera, A.; Rotoli, B.; Salvatore, F.; Sacchetti, L. | |
| Simultaneous occurrence of tetrasomy 21 and trisomy 8 in a patient with early blastic metamorphosis of chronic myeloproliferative disorder. | 1.1 Articolo in rivista | 1995 | Sebastio, L.; Ferrara, F.; Vicari, L.; DI NOTO, Rosa; DEL VECCHIO, Luigi; Pane, Fabrizio; Fasanaro, A.; Cimino, R.; Salvatore, Francesco; Ventruto, V. | |
| Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, philadelphia-positive chronic myeloid leukemia: the GIMEMA Working Party on CML. | 1.1 Articolo in rivista | 2008 | Francesca, Palandri; Ilaria, Iacobucci; Giovanni, Martinelli; Marilina, Amabile; Angela, Poerio; Nicoletta, Testoni; Simona, Soverini; Fausto, Castagnetti; Antonio De, Vivo; Massimo, Breccia; Giorgina, Specchia; Elisabetta, Abruzzese; Bruno, Martino; Daniela, Cilloni; Giuseppe, Saglio; Pane, Fabrizio; Anna Marina, Liberati; Gianantonio, Rosti; Michele, Baccarani; G. I., M. | |
| NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia. | 1.1 Articolo in rivista | 2008 | Brunangelo, Falini; Cristina, Mecucci; Giuseppe, Saglio; Francesco Lo, Coco; Daniela, Diverio; Patrick, Brown; Pane, Fabrizio; Marco, Mancini; Maria Paola, Martelli; Stefano, Pileri; Torsten, Haferlach; Claudia, Haferlach; Susanne, Schnittger | |
| Complete remission in a case of severe multi-resistant idiopathic thrombocytopenic purpura after Helicobacter pylori eradication. | 1.1 Articolo in rivista | 2008 | Ciro Roberto, Rinaldi; Andrea, Camera; Giovanni, Viscardi; Pane, Fabrizio; Bruno, Rotoli | |
| Livelli sierici degli isoenzimi della LDH e della pseudoridina in leucemie e linfomi | 1.1 Articolo in rivista | 1987 | Camera, A.; Savoia, Marcella; Fortunato, G.; Pane, Fabrizio; Buffardi, S.; Rotoli, B.; Salvatore, F.; Sacchetti, L. | |
| Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: tyrosine kinase inhibitor optimization and selectivity study. | 1.1 Articolo in rivista | 2010 | Cortes, Je; Baccarani, M; Guilhot, F; Druker, Bj; Branford, S; Kim, Dw; Pane, Fabrizio; Pasquini, R; Goldberg, Sl; Kalaycio, M; Moiraghi, B; Rowe, Jm; Tothova, E; De Souza, C; Rudoltz, M; Yu, R; Krahnke, T; Kantarjian, Hm; Radich, Jp; Hughes, T. P. | |
| Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan. | 1.1 Articolo in rivista | 2010 | Ferrara, F.; Izzo, T.; Criscuolo, C.; Riccardi, C.; Muccioli, G.; Viola, A.; Pane, Fabrizio; Palmieri, S. | |
| Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis. | 1.1 Articolo in rivista | 2010 | Castagnetti, F.; Testoni, N.; Luatti, S.; Marzocchi, G.; Mancini, M.; Kerim, S.; Giugliano, E.; Albano, F.; Cuneo, A.; Abruzzese, E.; Martino, B.; Palandri, F.; Amabile, M.; Iacobucci, I.; Alimena, G.; Pane, Fabrizio; Martinelli, G.; Saglio, G.; Baccarani, M.; Rosti, G. | |
| New insights into the Bcr-Abl activity-independent mechanisms of resistance to imatinib mesylate in KCL22 cells: the role of Shp1 and Shp2 | 4.1 Articoli in Atti di convegno | 2010 | Colavita, Irene; Esposito, Nicola; Martinelli, Rosanna; Catanzano, Francesca; Pane, Fabrizio; Ruoppolo, Margherita; Salvatore, Francesco |